Article info

Download PDFPDF

Original research
Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors

Authors

  • Charles Dolladille CHU de Caen, PICARO Cardio-oncology Program, Department of Pharmacology, CHU de Caen, Caen, France CHU de Caen, Department of Cardiology, CHU de Caen, Caen F-14000, France PubMed articlesGoogle scholar articles
  • Stephane Ederhy Department of Cardiology, Cardio-oncology Unit, Cardio-oncology Research G, INSERM U 856, Thrombose, Athérothrombose et Pharmacologie Appliquée, Assistance Publique - Hopitaux de Paris, Paris, France PubMed articlesGoogle scholar articles
  • Stéphane Allouche EA4650, Signalisation, Électrophysiologie et Imagerie des Lésions d'Ischémie-reperfusion Myocardique, Université de Caen Normandie, Caen, Normandie, France PubMed articlesGoogle scholar articles
  • Querntin Dupas EA4650, Signalisation, Électrophysiologie et Imagerie des Lésions d'Ischémie-reperfusion Myocardique, Université de Caen Normandie, Caen, Normandie, France PubMed articlesGoogle scholar articles
  • Radj Gervais Onco-pneumology, Centre François Baclesse Centre de Lutte Contre le Cancer, Caen, France PubMed articlesGoogle scholar articles
  • Jeannick Madelaine CHU de Caen, Onco-pneumology, CHU de Caen, Caen, France PubMed articlesGoogle scholar articles
  • Marion Sassier CHU de Caen, PICARO Cardio-oncology Program, Department of Pharmacology, CHU de Caen, Caen, France PubMed articlesGoogle scholar articles
  • Anne-Flore Plane CHU de Caen, Department of Cardiology, CHU de Caen, Caen F-14000, France PubMed articlesGoogle scholar articles
  • Francois Comoz CHU de Caen, Pathology, CHU de Caen, Caen, France PubMed articlesGoogle scholar articles
  • Ariel Aron Cohen Department of Cardiology, Cardio-oncology Unit, Cardio-oncology Research G, INSERM U 856, Thrombose, Athérothrombose et Pharmacologie Appliquée, Assistance Publique - Hopitaux de Paris, Paris, France PubMed articlesGoogle scholar articles
  • Franck Roland Thuny Mediterranean University Cardio-oncology Center (MEDI-CO Center), Unit of Heart Failure and Valvular Heart Diseases, Department of Cardiology, Hôpital Nord, Marseille, APHM, Marseille, Provence-Alpes-Côte d'Azu, France PubMed articlesGoogle scholar articles
  • Jennifer Cautela Mediterranean University Cardio-oncology Center (MEDI-CO Center), Unit of Heart Failure and Valvular Heart Diseases, Department of Cardiology, Hôpital Nord, Marseille, APHM, Marseille, Provence-Alpes-Côte d'Azu, France PubMed articlesGoogle scholar articles
  • Joachim Alexandre CHU de Caen, PICARO Cardio-oncology Program, Department of Pharmacology, CHU de Caen, Caen, France EA4650, Signalisation, Électrophysiologie et Imagerie des Lésions d'Ischémie-reperfusion Myocardique, Université de Caen Normandie, Caen, Normandie, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Charles Dolladille; cdolladille{at}hotmail.com
View Full Text

Citation

Dolladille C, Ederhy S, Allouche S, et al
Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors

Publication history

  • Accepted November 18, 2019
  • First published January 26, 2020.
Online issue publication 
January 26, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.